These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12534451)
1. Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes. Højlund K; Poulsen M; Staehr P; Brusgaard K; Beck-Nielsen H Eur J Clin Invest; 2002 Dec; 32(12):918-23. PubMed ID: 12534451 [TBL] [Abstract][Full Text] [Related]
2. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal. Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307 [TBL] [Abstract][Full Text] [Related]
4. Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes. Vind BF; Birk JB; Vienberg SG; Andersen B; Beck-Nielsen H; Wojtaszewski JF; Højlund K Diabetologia; 2012 May; 55(5):1435-45. PubMed ID: 22322917 [TBL] [Abstract][Full Text] [Related]
5. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects? Vaag A; Alford F; Beck-Nielsen H Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456 [TBL] [Abstract][Full Text] [Related]
6. In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes. Chun KH; Choi KD; Lee DH; Jung Y; Henry RR; Ciaraldi TP; Kim YB Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E536-42. PubMed ID: 21189360 [TBL] [Abstract][Full Text] [Related]
7. Increments in insulin sensitivity during intensive treatment are closely correlated with decrements in glucocorticoid receptor mRNA in skeletal muscle from patients with Type II diabetes. Vestergaard H; Bratholm P; Christensen NJ Clin Sci (Lond); 2001 Nov; 101(5):533-40. PubMed ID: 11672459 [TBL] [Abstract][Full Text] [Related]
8. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
10. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action. Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Mandarino LJ J Appl Physiol (1985); 2003 Dec; 95(6):2519-29. PubMed ID: 12909611 [TBL] [Abstract][Full Text] [Related]
12. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626 [TBL] [Abstract][Full Text] [Related]
13. Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes. Højlund K; Frystyk J; Levin K; Flyvbjerg A; Wojtaszewski JF; Beck-Nielsen H Diabetologia; 2006 Jun; 49(6):1283-91. PubMed ID: 16609880 [TBL] [Abstract][Full Text] [Related]
14. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356 [TBL] [Abstract][Full Text] [Related]
15. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856 [TBL] [Abstract][Full Text] [Related]
16. Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes. Pedersen AJ; Hingst JR; Friedrichsen M; Kristensen JM; Højlund K; Wojtaszewski JF Diabetologia; 2015 Jul; 58(7):1569-78. PubMed ID: 25870023 [TBL] [Abstract][Full Text] [Related]
17. Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity. Freymond D; Bogardus C; Okubo M; Stone K; Mott D J Clin Invest; 1988 Nov; 82(5):1503-9. PubMed ID: 2846655 [TBL] [Abstract][Full Text] [Related]
18. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects. Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615 [TBL] [Abstract][Full Text] [Related]
19. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378 [TBL] [Abstract][Full Text] [Related]